ArticleBreast cancer research : BCR2025

Comparison of trastuzumab deruxtecan and sacituzumab govitecan in HER2-negative metastatic breast cancer: a large real-world data analysis.

George W Jr Sledge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.